JUAN IGNACIO
ARCELUS MARTÍNEZ
PROFESOR TITULAR DE UNIVERSIDAD
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital General Universitario Gregorio Marañón (13)
2023
-
COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7
-
Machine learning to predict major bleeding during anticoagulation for venous thromboembolism: possibilities and limitations
British Journal of Haematology, Vol. 201, Núm. 5, pp. 971-981
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Predictors of use of direct oral anticoagulants in patients with venous thromboembolism: Findings from the Registro Informatizado Enfermedad Tromboembólica registry
Frontiers in Medicine, Vol. 9
2021
-
Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study
Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416
2019
-
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
The Lancet Oncology, Vol. 20, Núm. 10, pp. e566-e581
-
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years
Scientific Reports, Vol. 9, Núm. 1
-
Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry
Orphanet Journal of Rare Diseases, Vol. 14, Núm. 1
2018
-
Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU
Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 553-564
-
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism
American Journal of Medicine, Vol. 131, Núm. 4, pp. 430-437
2017
-
Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis
Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198
2015
-
A prognostic score to identify low-risk outpatients with acute deep vein thrombosis in the lower limbs
American Journal of Medicine, Vol. 128, Núm. 1, pp. 90.e9-90.e15
2008
-
Clinical presentation and time-course of postoperative venous thromboembolism: Results from the RIETE Registry
Thrombosis and Haemostasis, Vol. 99, Núm. 3, pp. 546-551